Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4600 | 1684 | 41.8 | 79% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
989 | 10020 | CHRONIC MYELOID LEUKEMIA//IMATINIB//BCR ABL |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MSSP | Author keyword | 4 | 46% | 0% | 6 |
2 | C MYC PROTEIN | Author keyword | 3 | 37% | 0% | 7 |
3 | ONCOGENE RESEARCH | Journal | 3 | 12% | 1% | 21 |
4 | PLASMACYTOMAGENESIS | Author keyword | 2 | 67% | 0% | 2 |
5 | ABL MYC | Author keyword | 1 | 100% | 0% | 2 |
6 | C MYC GENE PRODUCT | Author keyword | 1 | 100% | 0% | 2 |
7 | C MYC TRANSCRIPT | Author keyword | 1 | 100% | 0% | 2 |
8 | FOS JUN BINDING ACTIVITY | Author keyword | 1 | 100% | 0% | 2 |
9 | HUMAN C MYC | Author keyword | 1 | 50% | 0% | 2 |
10 | MYC ONCOGENES | Author keyword | 1 | 50% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MSSP | 4 | 46% | 0% | 6 | Search MSSP | Search MSSP |
2 | C MYC PROTEIN | 3 | 37% | 0% | 7 | Search C+MYC+PROTEIN | Search C+MYC+PROTEIN |
3 | PLASMACYTOMAGENESIS | 2 | 67% | 0% | 2 | Search PLASMACYTOMAGENESIS | Search PLASMACYTOMAGENESIS |
4 | ABL MYC | 1 | 100% | 0% | 2 | Search ABL+MYC | Search ABL+MYC |
5 | C MYC GENE PRODUCT | 1 | 100% | 0% | 2 | Search C+MYC+GENE+PRODUCT | Search C+MYC+GENE+PRODUCT |
6 | C MYC TRANSCRIPT | 1 | 100% | 0% | 2 | Search C+MYC+TRANSCRIPT | Search C+MYC+TRANSCRIPT |
7 | FOS JUN BINDING ACTIVITY | 1 | 100% | 0% | 2 | Search FOS+JUN+BINDING+ACTIVITY | Search FOS+JUN+BINDING+ACTIVITY |
8 | HUMAN C MYC | 1 | 50% | 0% | 2 | Search HUMAN+C+MYC | Search HUMAN+C+MYC |
9 | MYC ONCOGENES | 1 | 50% | 0% | 2 | Search MYC+ONCOGENES | Search MYC+ONCOGENES |
10 | ONCOPROTEIN P62C MYC | 1 | 100% | 0% | 2 | Search ONCOPROTEIN+P62C+MYC | Search ONCOPROTEIN+P62C+MYC |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | 1ST EXON | 20 | 50% | 2% | 29 |
2 | MODULATE EXPRESSION | 10 | 58% | 1% | 11 |
3 | ABERRANT REARRANGEMENT | 8 | 100% | 0% | 5 |
4 | MURINE PLASMACYTOMAS | 8 | 45% | 1% | 13 |
5 | PROMOTER SHIFT | 6 | 71% | 0% | 5 |
6 | MURINE PLASMACYTOMA | 6 | 58% | 0% | 7 |
7 | AVIAN MYELOCYTOMATOSIS VIRUS | 6 | 34% | 1% | 14 |
8 | MOUSE PLASMACYTOMAS | 5 | 40% | 1% | 10 |
9 | C MYC RECOMBINATIONS | 4 | 75% | 0% | 3 |
10 | ONC GENE | 3 | 29% | 1% | 10 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ONCOGENE RESEARCH | 3 | 12% | 1% | 21 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
CONTROL OF C-MYC REGULATION IN NORMAL AND NEOPLASTIC-CELLS | 1991 | 515 | 203 | 75% |
MYC FUNCTION AND REGULATION | 1992 | 757 | 412 | 60% |
NEW LIGHT ON MYC AND MYB .1. MYC | 1990 | 449 | 126 | 54% |
MYC FAMILY ONCOGENES IN THE DEVELOPMENT OF NORMAL AND NEOPLASTIC-CELLS | 1991 | 204 | 232 | 63% |
THE MYC ONCOGENE - ITS ROLE IN TRANSFORMATION AND DIFFERENTIATION | 1986 | 731 | 113 | 76% |
Myc translocations in B cell and plasma cell neoplasms | 2006 | 46 | 108 | 46% |
TRANSCRIPTION FACTORS .2. HELIX-LOOP-HELIX | 1995 | 86 | 1211 | 32% |
FUNCTION OF THE C-MYC ONCOPROTEIN | 1992 | 133 | 86 | 47% |
The c-myc story: Where we've been, where we seem to be going | 1997 | 32 | 88 | 40% |
ROLE OF MYC-AMPLIFICATION AND OVEREXPRESSION IN CELL-GROWTH, DIFFERENTIATION AND DEATH | 1993 | 76 | 93 | 39% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | HAARTMAN MOLEC CANC BIOL | 1 | 50% | 0.1% | 1 |
2 | IMMUNOL CHIKUSA KU | 1 | 50% | 0.1% | 1 |
3 | JAMES CANC HOSP INTERNAL MED | 1 | 50% | 0.1% | 1 |
4 | MED PREVENT MED COMMUNITY HLTH | 1 | 50% | 0.1% | 1 |
5 | MED VIRGINIA MED HEMATOL ONCOL | 1 | 50% | 0.1% | 1 |
6 | MEDECCLES HUMAN GENET | 1 | 50% | 0.1% | 1 |
7 | MOLEC CELLULAR CARDIOL | 1 | 50% | 0.1% | 1 |
8 | NMOB | 1 | 50% | 0.1% | 1 |
9 | ROCHE MOLEC ONCOL | 1 | 50% | 0.1% | 1 |
10 | TUMOR BIOL BOX 60400 | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000236626 | V ERB B//V ERBB//ACUTE RETROVIRUS |
2 | 0.0000208949 | MYC//MAX//C MYC |
3 | 0.0000138825 | ONCOGENIC RAS P21//EFFECTOR DOMAINS//N RAS |
4 | 0.0000093727 | C MYB//B MYB//V MYB |
5 | 0.0000090130 | CELL BIOL CANC GENET//MICROCELL HYBRIDIZATION//MICROCELL FUSION |
6 | 0.0000085263 | L MYC//H RAS MINISATELLITE//L MYC POLYMORPHISM |
7 | 0.0000077245 | FOLLICULAR LYMPHOMA//T1418//IN SITU FOLLICULAR LYMPHOMA |
8 | 0.0000074255 | FRA 1//JUN//V JUN |
9 | 0.0000071926 | DOUBLE MINUTE CHROMOSOMES//DOUBLE MINUTES//EXTRACHROMOSOMAL CIRCULAR DNA |
10 | 0.0000061424 | PRISTANE//PAR GENE//PRISTANE INDUCED LUPUS |